Stay informed with the latest updates for the inheritable blood disorders community.

Industry
Freeline Provides Updates on Hemophilia Gene Therapy Programs
Freeline Provides Updates on Hemophilia Gene Therapy Programs
Industry
Investigators Report Progress on New Subcutaneous Therapy
Investigators Report Progress on New Subcutaneous Therapy
Industry
Casebia Presents Dual Approach to Gene Therapy
Casebia Presents Dual Approach to Gene Therapy
Industry
BioMarin to Submit Marketing Applications to FDA and EMA
BioMarin to Submit Marketing Applications to FDA and EMA
Industry
Sanofi Presents Final Trial Data for rFVIII Candidate
Sanofi Presents Final Trial Data for rFVIII Candidate
Industry
uniQure Announces New Gene Therapy Trial Data
uniQure Announces New Gene Therapy Trial Data
Industry
Octapharma Presents Final Data on Personalized Therapy with Nuwiq®
Octapharma Presents Final Data on Personalized Therapy with Nuwiq®
Industry
Genentech Announces New Data from Hemlibra® Clinical Trial Program
Genentech Announces New Data from Hemlibra® Clinical Trial Program
Industry
Sangamo and Pfizer Announce Interim Gene Therapy Findings
Sangamo and Pfizer Announce Interim Gene Therapy Findings
Industry
BioMarin Provides Trial Updates for Hemophilia A Gene Therapy
BioMarin Provides Trial Updates for Hemophilia A Gene Therapy
Industry
ASC and Expression Therapeutics Collaborate on Hemophilia Gene Therapies
ASC and Expression Therapeutics Collaborate on Hemophilia Gene Therapies
Industry
Genentech Provides Updates on Hemlibra Product Particles
Bayer Announces Partnership with WFH Humanitarian Aid Program
Industry
Sigilon Releases Study Data on Hemophilia Cell Therapy
Sigilon Releases Study Data on Hemophilia Cell Therapy
Industry
uniQure Announces Updated Hemophilia B Gene Therapy Data
uniQure Announces Updated Hemophilia B Gene Therapy Data
Industry
Sangamo & Pfizer Report Hemophilia A Gene Therapy Trial Data
Sangamo & Pfizer Report Hemophilia A Gene Therapy Trial Data